TGF-β2

A novel target of CD44-promoted breast cancer invasion

Allal Ouhtit, Samineh Madani, Ishita Gupta, Somya Shanmuganathan, Mohamed E. Abdraboh, Hamad Al-Riyami, Yahya M. Al-Farsi, Madhwa H G Raj

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

We have developed a tetracycline (tet)-off regulated expression of CD44s gene in the breast cancer (BC) cell line MCF-7 (B5 clone) and identified TGF-β2 (Transforming Growth Factor beta- 2; 3 fold induction) as a potential CD44-downstream transcriptional target by microarray analysis. To further validate this finding, the same RNA samples, used for microarray analysis and their corresponding protein lysates, collected from the BC cell line MCF-7-B5, were examined for CD44 expression in the presence of HA. Our results showed that TGF-β2 mRNA levels were significantly elevated following theremoval of tetracycline at 18, 24, and 48 h post-HA stimulation compared to the parental cells. Furthermore, the TGF-β2 precursor protein increased in a time-dependent pattern upon HA-stimulation and in the absence of tetracycline. More interestingly, inhibition of CD44 gene by RNAi method decreased TGF-β2 expression upon HA-stimulation, and subsequently inhibited BC cell invasion in vitro. In addition to identifying TGF-β2 as a target for HA/CD44 signaling, this data suggests that ATF/CREB might be a potential transcription factor linking HA/CD44 activation to TGF-β2 transcription and additional experiments are required for a better understanding of the molecular mechanisms underpinning the novel function of the CD44/ TGF-β2 signaling pathway in breast cancer metastasis.

Original languageEnglish
Pages (from-to)566-572
Number of pages7
JournalJournal of Cancer
Volume4
Issue number7
DOIs
Publication statusPublished - 2013

Fingerprint

Transforming Growth Factor beta
Breast Neoplasms
Tetracycline
Microarray Analysis
Cell Line
Protein Precursors
RNA Interference
Transcription Factors
Clone Cells
RNA
Neoplasm Metastasis
Gene Expression
Messenger RNA
Genes
Proteins

Keywords

  • Breast cancer
  • Cd44
  • Cre/Atf
  • Hyaluronan
  • Mcf-7-B5 Clone
  • Metastasis
  • Tetracycline-Inducible
  • Tgf-β2

ASJC Scopus subject areas

  • Oncology

Cite this

Ouhtit, A., Madani, S., Gupta, I., Shanmuganathan, S., Abdraboh, M. E., Al-Riyami, H., ... Raj, M. H. G. (2013). TGF-β2: A novel target of CD44-promoted breast cancer invasion. Journal of Cancer, 4(7), 566-572. https://doi.org/10.7150/jca.6638

TGF-β2 : A novel target of CD44-promoted breast cancer invasion. / Ouhtit, Allal; Madani, Samineh; Gupta, Ishita; Shanmuganathan, Somya; Abdraboh, Mohamed E.; Al-Riyami, Hamad; Al-Farsi, Yahya M.; Raj, Madhwa H G.

In: Journal of Cancer, Vol. 4, No. 7, 2013, p. 566-572.

Research output: Contribution to journalArticle

Ouhtit, A, Madani, S, Gupta, I, Shanmuganathan, S, Abdraboh, ME, Al-Riyami, H, Al-Farsi, YM & Raj, MHG 2013, 'TGF-β2: A novel target of CD44-promoted breast cancer invasion', Journal of Cancer, vol. 4, no. 7, pp. 566-572. https://doi.org/10.7150/jca.6638
Ouhtit A, Madani S, Gupta I, Shanmuganathan S, Abdraboh ME, Al-Riyami H et al. TGF-β2: A novel target of CD44-promoted breast cancer invasion. Journal of Cancer. 2013;4(7):566-572. https://doi.org/10.7150/jca.6638
Ouhtit, Allal ; Madani, Samineh ; Gupta, Ishita ; Shanmuganathan, Somya ; Abdraboh, Mohamed E. ; Al-Riyami, Hamad ; Al-Farsi, Yahya M. ; Raj, Madhwa H G. / TGF-β2 : A novel target of CD44-promoted breast cancer invasion. In: Journal of Cancer. 2013 ; Vol. 4, No. 7. pp. 566-572.
@article{ca12cf055726431486485945ea14d6f7,
title = "TGF-β2: A novel target of CD44-promoted breast cancer invasion",
abstract = "We have developed a tetracycline (tet)-off regulated expression of CD44s gene in the breast cancer (BC) cell line MCF-7 (B5 clone) and identified TGF-β2 (Transforming Growth Factor beta- 2; 3 fold induction) as a potential CD44-downstream transcriptional target by microarray analysis. To further validate this finding, the same RNA samples, used for microarray analysis and their corresponding protein lysates, collected from the BC cell line MCF-7-B5, were examined for CD44 expression in the presence of HA. Our results showed that TGF-β2 mRNA levels were significantly elevated following theremoval of tetracycline at 18, 24, and 48 h post-HA stimulation compared to the parental cells. Furthermore, the TGF-β2 precursor protein increased in a time-dependent pattern upon HA-stimulation and in the absence of tetracycline. More interestingly, inhibition of CD44 gene by RNAi method decreased TGF-β2 expression upon HA-stimulation, and subsequently inhibited BC cell invasion in vitro. In addition to identifying TGF-β2 as a target for HA/CD44 signaling, this data suggests that ATF/CREB might be a potential transcription factor linking HA/CD44 activation to TGF-β2 transcription and additional experiments are required for a better understanding of the molecular mechanisms underpinning the novel function of the CD44/ TGF-β2 signaling pathway in breast cancer metastasis.",
keywords = "Breast cancer, Cd44, Cre/Atf, Hyaluronan, Mcf-7-B5 Clone, Metastasis, Tetracycline-Inducible, Tgf-β2",
author = "Allal Ouhtit and Samineh Madani and Ishita Gupta and Somya Shanmuganathan and Abdraboh, {Mohamed E.} and Hamad Al-Riyami and Al-Farsi, {Yahya M.} and Raj, {Madhwa H G}",
year = "2013",
doi = "10.7150/jca.6638",
language = "English",
volume = "4",
pages = "566--572",
journal = "Journal of Cancer",
issn = "1837-9664",
publisher = "Ivyspring International Publisher",
number = "7",

}

TY - JOUR

T1 - TGF-β2

T2 - A novel target of CD44-promoted breast cancer invasion

AU - Ouhtit, Allal

AU - Madani, Samineh

AU - Gupta, Ishita

AU - Shanmuganathan, Somya

AU - Abdraboh, Mohamed E.

AU - Al-Riyami, Hamad

AU - Al-Farsi, Yahya M.

AU - Raj, Madhwa H G

PY - 2013

Y1 - 2013

N2 - We have developed a tetracycline (tet)-off regulated expression of CD44s gene in the breast cancer (BC) cell line MCF-7 (B5 clone) and identified TGF-β2 (Transforming Growth Factor beta- 2; 3 fold induction) as a potential CD44-downstream transcriptional target by microarray analysis. To further validate this finding, the same RNA samples, used for microarray analysis and their corresponding protein lysates, collected from the BC cell line MCF-7-B5, were examined for CD44 expression in the presence of HA. Our results showed that TGF-β2 mRNA levels were significantly elevated following theremoval of tetracycline at 18, 24, and 48 h post-HA stimulation compared to the parental cells. Furthermore, the TGF-β2 precursor protein increased in a time-dependent pattern upon HA-stimulation and in the absence of tetracycline. More interestingly, inhibition of CD44 gene by RNAi method decreased TGF-β2 expression upon HA-stimulation, and subsequently inhibited BC cell invasion in vitro. In addition to identifying TGF-β2 as a target for HA/CD44 signaling, this data suggests that ATF/CREB might be a potential transcription factor linking HA/CD44 activation to TGF-β2 transcription and additional experiments are required for a better understanding of the molecular mechanisms underpinning the novel function of the CD44/ TGF-β2 signaling pathway in breast cancer metastasis.

AB - We have developed a tetracycline (tet)-off regulated expression of CD44s gene in the breast cancer (BC) cell line MCF-7 (B5 clone) and identified TGF-β2 (Transforming Growth Factor beta- 2; 3 fold induction) as a potential CD44-downstream transcriptional target by microarray analysis. To further validate this finding, the same RNA samples, used for microarray analysis and their corresponding protein lysates, collected from the BC cell line MCF-7-B5, were examined for CD44 expression in the presence of HA. Our results showed that TGF-β2 mRNA levels were significantly elevated following theremoval of tetracycline at 18, 24, and 48 h post-HA stimulation compared to the parental cells. Furthermore, the TGF-β2 precursor protein increased in a time-dependent pattern upon HA-stimulation and in the absence of tetracycline. More interestingly, inhibition of CD44 gene by RNAi method decreased TGF-β2 expression upon HA-stimulation, and subsequently inhibited BC cell invasion in vitro. In addition to identifying TGF-β2 as a target for HA/CD44 signaling, this data suggests that ATF/CREB might be a potential transcription factor linking HA/CD44 activation to TGF-β2 transcription and additional experiments are required for a better understanding of the molecular mechanisms underpinning the novel function of the CD44/ TGF-β2 signaling pathway in breast cancer metastasis.

KW - Breast cancer

KW - Cd44

KW - Cre/Atf

KW - Hyaluronan

KW - Mcf-7-B5 Clone

KW - Metastasis

KW - Tetracycline-Inducible

KW - Tgf-β2

UR - http://www.scopus.com/inward/record.url?scp=84882974399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882974399&partnerID=8YFLogxK

U2 - 10.7150/jca.6638

DO - 10.7150/jca.6638

M3 - Article

VL - 4

SP - 566

EP - 572

JO - Journal of Cancer

JF - Journal of Cancer

SN - 1837-9664

IS - 7

ER -